Biosenta Inc.

Equities

ZRO

CA09072N2023

Household Products

Market Closed - Canadian Securities Exchange 10:15:44 2024-04-25 am EDT 5-day change 1st Jan Change
0.335 CAD 0.00% Intraday chart for Biosenta Inc. -25.56% +52.27%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Biosenta Inc. announced that it expects to receive CAD 0.6 million in funding CI
Biosenta Inc. Announces Successful Launch of Bench Scale Production Plant CI
Biosenta Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
Biosenta Inc. Reports Earnings Results for the Full Year Ended September 30, 2023 CI
Biosenta Inc. announced that it has received CAD 0.5 million in funding CI
Biosenta Inc. announced that it expects to receive CAD 0.5 million in funding CI
Biosenta Inc. Announces Breakthrough Discovery in Anti-Microbial Efficacy of Tri-Filler in Collaboration with University of Calgary CI
Biosenta Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023 CI
Biosenta Inc. Announces Further Advances in Research and Development of Tri-Filler CI
Biosenta Inc. Announces Entering into of Agreement to Terminate Joint Venture CI
Biosenta Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023 CI
Biosenta Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022 CI
Biosenta Inc. Reports Earnings Results for the Full Year Ended September 30, 2022 CI
Biosenta Inc. Auditor Raises 'Going Concern' Doubt CI
Biosenta Signs MoU with Voran Group Ventures for Commercialization of Biosenta's Tri-Filler Products MT
Biosenta Inc. Enters into an MOU with Voran Group Ventures Ltd. to Collaborate on the Commercialization of Biosenta's Tri-Filler® Products CI
Biosenta Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022 CI
Biosenta Inc. Develops Environmentally Friendly Biocidal Particles in Collaboration with University of Calgary CI
Biosenta Inc. Reports Earnings Results for the First Quarter Ended December 31, 2021 CI
Biosenta Inc. Reports Earnings Results for the Full Year Ended September 30, 2021 CI
Biosenta Inc. Auditor Raises 'Going Concern' Doubt CI
Biosenta Inc. Reports Earnings Results for the Third Quarter Ended June 30, 2021 CI
Biosenta Inc. Reports Earnings Results for the Second Quarter Ended March 31, 2021 CI
Biosenta Inc. Reports Earnings Results for the Full Year Ended September 30, 2020 CI
Biosenta Inc. announced that it has received CAD 0.085 million in funding CI
Chart Biosenta Inc.
More charts
Biosenta Inc. is engaged in developing, producing, and manufacturing an array of chemical compounds for household and industrial applications, utilizing advanced encapsulated nanotechnology. It also develops chemical compounds designed to eliminate harmful microorganisms, such as bacteria, fungi, and viruses for household and industrial uses, while ensuring safety for both humans and the environment. It offers true Disinfectant and Tri-Filler. The true disinfectant is recognized by Health Canada for use in the fight against COVID-19. Its true technology leads the charge against the threat of superbug pathogens. The Tri-Filler's Nano-technology particles provide anti-microbial protection while preventing the growth of mold, bacteria and viruses. Tri-Filler are embedded to protect various materials, including drywall, plastic and resin, from microbe formation. These compounds remain to protect the drywall of buildings, objects, such as resin furniture, resin, textiles and others.
More about the company
  1. Stock Market
  2. Equities
  3. ZRO Stock
  4. News Biosenta Inc.
  5. Biosenta Signs MoU with Voran Group Ventures for Commercialization of Biosenta's Tri-Filler Products